Martingale Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,406
Closed -$249K 838
2023
Q2
$249K Hold
5,406
﹤0.01% 728
2023
Q1
$217K Hold
5,406
﹤0.01% 767
2022
Q4
$250K Hold
5,406
﹤0.01% 749
2022
Q3
$224K Buy
5,406
+1,200
+29% +$49.7K ﹤0.01% 763
2022
Q2
$251K Buy
+4,206
New +$251K ﹤0.01% 767